Categories

Tags

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Date
March 22, 2021
Co-Chairs
Jay D. Horton, MD
University of Texas Southwestern Medical Center
Alphonse E. Sirica, PhD
Virginia Commonwealth University
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
Date
March 22, 2021
Speaker
Lopa Mishra, MD
George Washington University
Coffee Break
Date
March 22, 2021
The Gut-Liver Axis in Liver Cancer Risk Conditions
Date
March 22, 2021
Speaker
Maria Rescigno, PhD
Humanitas University
Lipid Dysregulation in Inflammation, NASH, and Cancer
Date
March 22, 2021
Speaker
Daniel A. Heller, PhD
Memorial Sloan Kettering Cancer Center
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
Date
March 22, 2021
Speaker
Juan R. Sanabria, MD
Marshall University/Case Western Reserve University

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.